TAO Kinase 2 anticorps (AA 719-880)
-
- Antigène Voir toutes TAO Kinase 2 (TAOK2) Anticorps
- TAO Kinase 2 (TAOK2)
-
Épitope
- AA 719-880
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp TAO Kinase 2 est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Serine/threonine-protein kinase TAO2 protein (719-880AA)
- Isotype
- IgG
- Top Product
- Discover our top product TAOK2 Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: IHC:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- TAO Kinase 2 (TAOK2)
- Autre désignation
- TAOK2 (TAOK2 Produits)
- Synonymes
- anticorps MAP3K17, anticorps PSK, anticorps PSK1, anticorps PSK1-BETA, anticorps TAO1, anticorps TAO2, anticorps Tao2, anticorps 1110033K02Rik, anticorps B230344N16, anticorps mKIAA0881, anticorps TAOK2, anticorps map3k17, anticorps psk, anticorps psk1, anticorps tao1, anticorps tao2, anticorps TAO kinase 2, anticorps TAO kinase 2 L homeolog, anticorps serine/threonine-protein kinase TAO2, anticorps TAOK2, anticorps Taok2, anticorps taok2.L, anticorps taok2, anticorps LOC100085396
- Sujet
-
Background: Serine/threonine-protein kinase involved in different processes such as membrane blebbing and apoptotic bodies formation DNA damage response and MAPK14/p38 MAPK stress-activated MAPK cascade. Phosphorylates itself, MBP, activated MAPK8, MAP2K3, MAP2K6 and tubulins. Activates the MAPK14/p38 MAPK signaling pathway through the specific activation and phosphorylation of the upstream MAP2K3 and MAP2K6 kinases. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Isoform 1, but not isoform 2, plays a role in apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation. This function, which requires the activation of MAPK8/JNK and nuclear localization of C-terminally truncated isoform 1, may be linked to the mitochondrial CASP9-associated death pathway. Isoform 1 binds to microtubules and affects their organization and stability independently of its kinase activity. Prevents MAP3K7-mediated activation of CHUK, and thus NF-kappa-B activation, but not that of MAPK8/JNK. May play a role in the osmotic stress-MAPK8 pathway. Isoform 2, but not isoform 1, is required for PCDH8 endocytosis. Following homophilic interactions between PCDH8 extracellular domains, isoform 2 phosphorylates and activates MAPK14/p38 MAPK which in turn phosphorylates isoform 2. This process leads to PCDH8 endocytosis and CDH2 cointernalization. Both isoforms are involved in MAPK14 phosphorylation.
Aliases: 1110033K02Rik antibody, B230344N16 antibody, hKFC C antibody, hKFC-C antibody, KIAA0881 antibody, Kinase from chicken homolog C antibody, MAP3K17 antibody, mKIAA0881 antibody, Prostate derived STE20 like kinase 1 antibody, Prostate derived STE20 like kinase PSK antibody, Prostate derived sterile 20 like kinase 1 antibody, Prostate-derived STE20-like kinase 1 antibody, PSK 1 antibody, PSK antibody, PSK-1 antibody, PSK1 antibody, PSK1 beta antibody, Serine/threonine protein kinase TAO2 antibody, Serine/threonine-protein kinase TAO2 antibody, TAO 1 antibody, TAO 2 antibody, TAO kinase 2 antibody, TAO1 antibody, TAO2 antibody, TAOK 2 antibody, Taok2 antibody, TAOK2_HUMAN antibody, Thousand and one amino acid protein 2 antibody, Thousand and one amino acid protein kinase antibody, UNQ2971/PRO7431 antibody
- UniProt
- Q9UL54
- Pathways
- Cell-Cell Junction Organization
-